Clinical Trial Update: A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL [Phase 4]

View source ↗

Summary

A non-randomized, open-label Phase 4 clinical trial evaluating DermaBind TL for diabetic foot ulcers and venous leg ulcers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Venous Leg Ulcer

Drugs mentioned

• DermaBind TL

Snippet

Sponsor: HealthTech Wound Care | Conditions: Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU) | Phase 4 | Status: RECRUITING